
In a striking political reversal that has reverberated across the US, Donald Trump and Mark Cuban have officially joined forces to expand the TrumpRx drug pricing platform.
The initiative, designed to act as a centralised hub for affordable generic medications, aims to challenge the opacity of the current pharmaceutical landscape.